Standard therapy for the treatment of acute pulmonary embolism (PE) consists of regimes involving anticoagulation therapy alone. Thrombolytic therapy (TT) may provide a mechanism for more rapid thrombus resolution and improvement in pulmonary blood flow and may therefore offer benefit among certain patient groups, such as those presenting with features of cardiopulmonary compromise. However, previous […]